When a randomized controlled trial is unlikely: Propensity score analysis of blinatumomab in adults with relapsed/refractory Philadelphia chromosome–positive B‐cell acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

When a randomized controlled trial is unlikely: Propensity score analysis of blinatumomab in adults with relapsed/refractory Philadelphia chromosome–positive B‐cell acute lymphoblastic leukemia

Published:2019-10-18 Issue:2 Volume:126 Page:253-255
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Cassaday Ryan D.¹²

Affiliation:

1. Division of Hematology Department of Medicine University of Washington School of Medicine Seattle Washington

2. Clinical Research Division Fred Hutchinson Cancer Research Center Seattle Washington

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32565

Reference11 articles.

1. Defining the course and prognosis of adults with acute lymphocytic leukemia in first salvage after induction failure or short first remission duration

2. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study

3. Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia

4. Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia

5. Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. External control arm analysis: an evaluation of propensity score approaches, G-computation, and doubly debiased machine learning;BMC Medical Research Methodology;2022-12-28

2. External control arm analysis: an evaluation of propensity score approaches, G-computation, and doubly debiased machine learning;2022-01-30